Journal article
Impact of Sex on Cardiovascular Outcome in Patients at High Cardiovascular Risk
Abstract
BACKGROUND: Epidemiological data suggest that sex independently contributes to cardiovascular risk. Clinical trials are often hampered by the enrollment of few female patients.
METHODS AND RESULTS: The Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial (ONTARGET) and the parallel Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease (TRANSCEND) included a large proportion …
Authors
Kappert K; Böhm M; Schmieder R; Schumacher H; Teo K; Yusuf S; Sleight P; Unger T
Journal
Circulation, Vol. 126, No. 8, pp. 934–941
Publisher
Wolters Kluwer
Publication Date
August 21, 2012
DOI
10.1161/circulationaha.111.086660
ISSN
0009-7322